OMO-103

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameOMO-103
Drug Alias NameOMO-103OMO103
ClassificationBiologics
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Renal Cell +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeptomyc SL
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalOsteosarcoma
Inactive IndicationsSolid tumoursCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A